Joint Statistical Meeting (JSM)

August 2–7 2025, Nashville, USA

test header

Share

JSM

Hematology

Nashville

Poster

Global Manufacturing Experience With Idecabtagene Vicleucel (Ide-Cel) In Patients With Relapsed and Refractory Multiple Myeloma

Surbhi Sidana, Christof Scheid, Peter J. Mueller, Petra Schuberth, Hardik Modi, Peter Krengel, Romain Piault, Xiaobo Zhong, Paula Rodríguez-Otero.

U.S. Medical Information & Services

Access medical information and resources for U.S. healthcare professionals.

Medical Information Online  External new tab
Medical Information Contact Center

800-321-1335 (toll free U.S. only)

Mon - Fri, 8am - 5pm ET

Report Adverse Events or Product Quality Complaints

800-721-5072 (toll free U.S. only)

For outside the U.S., visit our global site to report Adverse Events, Product Quality Complaints or submit a Medical Information inquiry.

Follow us

      

Legal notice  External new tab

Privacy notice center  External new tab

Your Privacy Choices

Trademarks  External new tab

© 2025 Bristol-Myers Squibb Company
BMS Medical is a trademark of Bristol-Myers Squibb Company
466-US-2500229 8/25